肝病

订阅

MedSci主页 / 所有栏目 / 肝病

J Viral Hepat：Toll样受体4多态性与印度患者感染戊型肝炎病毒的关系

2018-08-21 MedSci MedSci原创

Toll-likereceptor4多态性hepatitisEvirus
关注

研究首次报道了TLR4多态性与戊型肝炎的关系，并提示HEV感染时TLR4低反应性可能与其多态性有关。

戊型肝炎病毒(HEV)引起的戊型肝炎感染是发展中国家的一项重大公共卫生问题，是成人散发性和流行性急性病毒性肝炎的病因。人们对戊型肝炎感染的发病机理知之甚少。Toll样受体(TLRs)是固有免疫识别病原体相关分子模式(PAMPs)中的关键角色。

在此之前，研究组发现在HEV感染患者中，TLR 4高表达(在蛋白和基因水平上)与LPS刺激单个核细胞后细胞因子反应受损有关。针对TLR4基因(A299G， C399T)多态性与肝病相关性的早期观察，本研究对HEV感染患者的TLR4多态性进行了探究。

研究观察到TLR4-399CC和CT等位基因与戊型肝炎(亚临床和急性患者)显著相关。与对照组相比，TLR4-399 CT在患者类别中的载波频率较低。TLR4-399C等位基因频率较高与疾病进展显著相关。急性肝病患者CG和TA单倍型的频率更高，而罕见的单倍型(TG)在对照组中更高。TLR4-299 (A>G)上的单核苷酸多态性(SNP)没有显示任何差异。

研究首次报道了TLR4多态性与戊型肝炎的关系，并提示HEV感染时TLR4低反应性可能与其多态性有关。

原始出处

Arya RP， Mishra N， Biswas K， et al. Association of Toll-like receptor 4 polymorphism with Hepatitis E virus infected Indian patients.J Viral Hepat， 2018， Aug 16. doi： 10.1111/jvh.12980.

本文系梅斯医学（MedSci）原创编译整理，转载需授权！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1427199, encodeId=1b5f142e199c1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443105, encodeId=af55144310592, content=<a href='/topic/show?id=34b3538088b' target=_blank style='color:#2F92EE;'>#戊型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53808, encryptionId=34b3538088b, topicName=戊型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=828f5025371, createdName=ms1779634646866130, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629267, encodeId=ab57162926e65, content=<a href='/topic/show?id=0c1c4325170' target=_blank style='color:#2F92EE;'>#多态性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43251, encryptionId=0c1c4325170, topicName=多态性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d83c21331263, createdName=xzw120, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339974, encodeId=65e53399e406, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Aug 21 18:59:01 CST 2018, time=2018-08-21, status=1, ipAttribution=)]
    2018-08-23 gwc384

    #EPA#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1427199, encodeId=1b5f142e199c1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443105, encodeId=af55144310592, content=<a href='/topic/show?id=34b3538088b' target=_blank style='color:#2F92EE;'>#戊型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53808, encryptionId=34b3538088b, topicName=戊型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=828f5025371, createdName=ms1779634646866130, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629267, encodeId=ab57162926e65, content=<a href='/topic/show?id=0c1c4325170' target=_blank style='color:#2F92EE;'>#多态性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43251, encryptionId=0c1c4325170, topicName=多态性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d83c21331263, createdName=xzw120, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339974, encodeId=65e53399e406, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Aug 21 18:59:01 CST 2018, time=2018-08-21, status=1, ipAttribution=)]
    2018-08-23 ms1779634646866130

    #戊型肝炎#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1427199, encodeId=1b5f142e199c1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443105, encodeId=af55144310592, content=<a href='/topic/show?id=34b3538088b' target=_blank style='color:#2F92EE;'>#戊型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53808, encryptionId=34b3538088b, topicName=戊型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=828f5025371, createdName=ms1779634646866130, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629267, encodeId=ab57162926e65, content=<a href='/topic/show?id=0c1c4325170' target=_blank style='color:#2F92EE;'>#多态性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43251, encryptionId=0c1c4325170, topicName=多态性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d83c21331263, createdName=xzw120, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339974, encodeId=65e53399e406, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Aug 21 18:59:01 CST 2018, time=2018-08-21, status=1, ipAttribution=)]
    2018-08-23 xzw120

    #多态性#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1427199, encodeId=1b5f142e199c1, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443105, encodeId=af55144310592, content=<a href='/topic/show?id=34b3538088b' target=_blank style='color:#2F92EE;'>#戊型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53808, encryptionId=34b3538088b, topicName=戊型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=828f5025371, createdName=ms1779634646866130, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629267, encodeId=ab57162926e65, content=<a href='/topic/show?id=0c1c4325170' target=_blank style='color:#2F92EE;'>#多态性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43251, encryptionId=0c1c4325170, topicName=多态性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d83c21331263, createdName=xzw120, createdTime=Thu Aug 23 09:20:00 CST 2018, time=2018-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339974, encodeId=65e53399e406, content=谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Tue Aug 21 18:59:01 CST 2018, time=2018-08-21, status=1, ipAttribution=)]
    2018-08-21 清风拂面

    谢谢分享学习

    0

相关资讯

J Hepatol：在小鼠肝脏中，肝肠轴对缺血再灌注-调节的肝癌复发的作用

通过RIPC、肠道灭菌和Tlr4拮抗的方法，对肝肠轴和LPS-Tlr4的反应进行调节，这是预防I/R病变的潜在治疗靶点，并在肝移植和切除后减轻肝癌复发。